Anavex Life Sciences Future Growth
How is Anavex Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score
5/6Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
53.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2025 | 232 | 134 | N/A | 139 | 2 |
9/30/2024 | 45 | -38 | -47 | -34 | 3 |
9/30/2023 | 2 | -58 | -57 | -57 | 3 |
9/30/2022 | N/A | -48 | -24 | -24 | N/A |
6/30/2022 | N/A | -45 | -28 | -28 | N/A |
3/31/2022 | N/A | -43 | -28 | -28 | N/A |
12/31/2021 | N/A | -41 | -26 | -26 | N/A |
9/30/2021 | N/A | -38 | -30 | -30 | N/A |
6/30/2021 | N/A | -32 | -29 | -29 | N/A |
3/31/2021 | N/A | -28 | -25 | -25 | N/A |
12/31/2020 | N/A | -28 | -23 | -23 | N/A |
9/30/2020 | N/A | -26 | -21 | -21 | N/A |
6/30/2020 | N/A | -26 | -18 | -18 | N/A |
3/31/2020 | N/A | -26 | -21 | -21 | N/A |
12/31/2019 | N/A | -26 | -20 | -20 | N/A |
9/30/2019 | N/A | -26 | -19 | -19 | N/A |
6/30/2019 | N/A | -26 | -20 | -20 | N/A |
3/31/2019 | N/A | -23 | -15 | -15 | N/A |
12/31/2018 | N/A | -20 | -13 | -13 | N/A |
9/30/2018 | N/A | -17 | -13 | -13 | N/A |
6/30/2018 | N/A | -17 | -11 | -11 | N/A |
3/31/2018 | N/A | -18 | -12 | -12 | N/A |
12/31/2017 | N/A | -14 | -9 | -9 | N/A |
9/30/2017 | N/A | -13 | -9 | -9 | N/A |
6/30/2017 | N/A | -15 | -9 | -9 | N/A |
3/31/2017 | N/A | -13 | -8 | -8 | N/A |
12/31/2016 | N/A | -14 | -9 | -9 | N/A |
9/30/2016 | N/A | -15 | -9 | -9 | N/A |
6/30/2016 | N/A | -14 | N/A | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVXL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: AVXL is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AVXL is expected to become profitable in the next 3 years.
Revenue vs Market: AVXL's revenue (50.7% per year) is forecast to grow faster than the US market (7.1% per year).
High Growth Revenue: AVXL's revenue (50.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AVXL's Return on Equity is forecast to be high in 3 years time